1. Home
  2. ZDGE vs BOLD Comparison

ZDGE vs BOLD Comparison

Compare ZDGE & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zedge Inc. Class B

ZDGE

Zedge Inc. Class B

HOLD

Current Price

$3.21

Market Cap

44.1M

Sector

Technology

ML Signal

HOLD

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

HOLD

Current Price

$1.56

Market Cap

36.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZDGE
BOLD
Founded
2008
2018
Country
United States
United States
Employees
55
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
44.1M
36.5M
IPO Year
2016
2024

Fundamental Metrics

Financial Performance
Metric
ZDGE
BOLD
Price
$3.21
$1.56
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.00
AVG Volume (30 Days)
66.2K
366.0K
Earning Date
06-11-2026
05-06-2026
Dividend Yield
1.96%
N/A
EPS Growth
73.85
32.47
EPS
N/A
N/A
Revenue
$29,398,000.00
N/A
Revenue This Year
$3.27
N/A
Revenue Next Year
$5.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.12
$0.96
52 Week High
$4.70
$1.72

Technical Indicators

Market Signals
Indicator
ZDGE
BOLD
Relative Strength Index (RSI) 51.03 61.19
Support Level $2.90 $1.12
Resistance Level $3.19 $1.55
Average True Range (ATR) 0.19 0.08
MACD -0.00 -0.01
Stochastic Oscillator 36.00 52.17

Price Performance

Historical Comparison
ZDGE
BOLD

About ZDGE Zedge Inc. Class B

Zedge Inc builds digital marketplaces and competitive games centered on content that people use for self-expression. Its products include the Zedge App, a freemium digital content marketplace offering mobile wallpapers, video wallpapers, ringtones, and notification sounds, along with pAInt, a generative AI wallpaper and ringtone maker, GuruShots, a skill-based photo challenge game, and Emojipedia, a trusted source for emoji information. The Zedge App is available on Google Play and the App Store. The company operates two segments: Zedge Marketplace and GuruShots, with the majority of revenue generated from the Zedge Marketplace.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Using its proprietary Spyglass platform, the company identifies targets essential for ecDNA functionality, then designs and develops small-molecule drugs called ecDNA-directed therapies (ecDTx) to inhibit those targets. Its main ecDTx candidate under development, BBI-940, is a novel, oral, selective degrader that has demonstrated potent anti-tumor activity across a range of cancer cell lines and mouse xenograft models, including single-agent tumor regressions.

Share on Social Networks: